BioStock: Cereno Scientific aligns with FDA on CS1 development

Cereno Scientific has taken another important step forward with lead candidate CS1. Yesterday, the Swedish biotech held a constructive Type C meeting with the U.S. Food and Drug Administration. The discussions suggest alignment between Cereno Scientific and the FDA on the development path.

Read the full article at biostock.se:

https://www.biostock.se/en/2025/04/cereno-scientific-aligns-with-fda-on-cs1-development/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se